orthochromatic

(redirected from ortho)
Also found in: Dictionary, Medical, Financial, Acronyms, Wikipedia.

orthochromatic

[‚ȯr·thə·krə′mad·ik]
(biology)
Having normal staining characteristics.
(graphic arts)
Pertaining to sensitized materials that can be exposed by ultraviolet, blue, and green light, but not deep orange or red.
References in periodicals archive ?
She sued the company, alleging that Ortho Evra was insufficiently tested and that "the defendants' intentional and/or reckless failure to disclose information deprived [the] plaintiff of necessary information to enable her to weigh the true risks of using the subject product against its benefits.
Both studies are funded by Johnson & Johnson Pharmaceutical Research and Development, parent company for Ortho.
The compact complements the Ortho Dialpak tablet dispenser.
Johnson & Johnson spokesperson Bob Kniffin told SCIENCE NEWS that Ortho continues to view space as "a very practical approach to manufacturing.
The analyser for ORTHO Column Agglutination Technologies will become commercially available in Europe, Japan and Australia by the end of the year.
The Ortho spokeswoman says that Monistat 7 was the best-seller as a prescription product, accounting for 59% of the 13 million prescriptions written for vaginal antifungal treatments in 1989, and that Ortho expects that success to continue.
The FDA approved the label changes on January 18, 2008, in response to research findings from the Boston Collaborative Drug Surveillance Program (BCDSP) on behalf of Johnson & Johnson, maker of Ortho Evra Contraceptive Transdermal Patch.
Ortho and its affiliates have been on the move in recent weeks.
19 January 2012 - Ortho Caps GmbH, a German dental products company, has challenged several of Align Technology Inc's (NASDAQ:ALGN) European patents, as a response to Align Technology's patent infringement lawsuit filed against Ortho Caps on 21 December 2011 in the District Court of Dusseldorf.
M2 PHARMA-September 7, 2011-Inter Ortho broadens portfolio with Sober buy(C)2011 M2 COMMUNICATIONS
M2 PHARMA-December 21, 2010-Centocor Ortho Biotech seeks FDA nod for abiraterone acetate for metastatic advanced prostate cancer treatment(C)2010 M2 COMMUNICATIONS
In addition to cosmetic plastic surgery, MediaFact recently added sections on Stevens-Johnson Syndrome, health issues resulting from use of the Ortho Evra Patch (Ortho-McNeil Pharmaceutical, Inc.